Masayoshi Yada Selected Research

Masayoshi Yada Research Topics

Disease

8	Hepatocellular Carcinoma (Hepatoma) 07/2022 - 09/2014
7	Neoplasms (Cancer) 07/2022 - 08/2006
4	Non-alcoholic Fatty Liver Disease 05/2009 - 09/2007
3	Chronic Hepatitis C 02/2013 - 03/2010
2	Infections 01/2022 - 04/2018
2	Liver Cirrhosis (Hepatic Cirrhosis) 08/2017 - 08/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Pancreatic Intraductal Neoplasms 01/2022
1	Lupus Nephritis 01/2022
1	Cholangiocarcinoma 06/2021
1	Liver Diseases (Liver Disease) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Sclerosing Cholangitis 01/2021
1	Abdominal Pain (Pain, Abdominal) 01/2020
1	Toxocariasis 01/2020
1	Chronic Hepatitis B 01/2020
1	Anemia 04/2018
1	Fatigue 04/2018
1	Fibrosis (Cirrhosis) 08/2016
1	Acute Liver Failure (Fulminant Hepatic Failure) 08/2016
1	Hand-Foot Syndrome 09/2014
1	Liver Neoplasms (Liver Cancer) 09/2014
1	Diarrhea 09/2014
1	Alopecia (Baldness) 09/2014
1	Hypertension (High Blood Pressure) 09/2014
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 09/2009
1	Insulin Resistance 11/2008
1	Machado-Joseph Disease (Spinocerebellar Ataxia Type 3) 02/2004

Drug/Important Bio-Agent (IBA)

5	Fatty Acids (Saturated Fatty Acids)IBA 09/2010 - 09/2007
3	InterferonsIBA 01/2022 - 03/2010
3	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 09/2014
3	EnzymesIBA 01/2021 - 11/2008
3	CholesterolIBA 09/2010 - 05/2009
2	CateninsIBA 07/2022 - 02/2022
2	Ribavirin (Virazole)FDA LinkGeneric 04/2018 - 02/2013
2	PPAR alphaIBA 11/2008 - 09/2007
2	Sterol Regulatory Element Binding Protein 1IBA 04/2008 - 09/2007
1	Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA 07/2022
1	atezolizumabIBA 07/2022
1	Bevacizumab (Avastin)FDA Link 07/2022
1	lenvatinibIBA 02/2022
1	Vitamin K FDA Link 02/2022
1	gadolinium ethoxybenzyl DTPA FDA Link 02/2022
1	Fetal Proteins (Fetoprotein)IBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 06/2021
1	Keratin-7 (Cytokeratin 7)IBA 06/2021
1	Keratin-19 (Keratin 19)IBA 06/2021
1	pembrolizumabIBA 01/2021
1	SteroidsIBA 01/2021
1	entecavir FDA Link 01/2020
1	Albendazole (Albenza)FDA Link 01/2020
1	SofosbuvirIBA 04/2018
1	Tolvaptan FDA Link 08/2017
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 08/2016
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 08/2016
1	thiamine triphosphorate (TTP)IBA 09/2014
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 09/2014
1	pitavastatin (itavastatin)FDA Link 02/2013
1	Eicosapentaenoic AcidIBA 02/2013
1	RNA (Ribonucleic Acid)IBA 03/2010
1	microsomal triglyceride transfer proteinIBA 05/2009
1	LDL Receptors (LDL Receptor)IBA 05/2009
1	Triglycerides (Triacylglycerol)IBA 11/2008
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2008
1	Insulin ReceptorIBA 04/2008
1	Insulin (Novolin)FDA Link 04/2008
1	AMP-Activated Protein KinasesIBA 04/2008
1	AntioxidantsIBA 09/2007
1	Complement System Proteins (Complement)IBA 09/2007
1	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 09/2007
1	CatalaseIBA 09/2007
1	Cyclin EIBA 08/2006
1	Proteins (Proteins, Gene)FDA Link 08/2006
1	UbiquitinIBA 08/2006
1	Ataxin-3IBA 02/2004
1	polyglutamineIBA 02/2004
1	Proteasome Endopeptidase Complex (Proteasome)IBA 02/2004

Therapy/Procedure

4	Therapeutics 07/2022 - 02/2013
1	Renal Dialysis (Hemodialysis) 01/2022
1	Aftercare (After-Treatment) 01/2020
1	Drug Tapering 04/2018